B

Baroness Merron (Lab)

Speaking in the House of Lords on 17 November 2026

Debate

Health Bill

Contribution

I understand the point that the noble Baroness, Lady Barker, is making. I could make a number of points on masculinising and feminising hormones, but the point raised particularly by the noble Lord, Lord Scriven, and the noble Baroness, Lady Cash, was about unsafe online and international prescriptions. The General Pharmaceutical Council, the CQC and the Medicines and Healthcare products Regulatory Agency have powers to investigate and act. They have our full support. I should add that last year we sought evidence on private prescribing, including online services and medicines obtained from prescribers in the European Economic Area. We are looking at the responses before deciding on next steps, because we recognise the concerns of the noble Baroness and the noble Lord. The noble Lord, Lord Scriven, asked about the order made in February this year for the study under the Gender Recognition Act. I can confirm that we are confident the order provides the necessary legal protections to facilitate the sharing of data required for the study.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.